PREPARE - Primary Prevention Parameters Evaluation

Completed · Not applicable

Conditions studied: Tachycardia, Ventricular, Implantable Cardioverter Defibrillator (ICD), Fibrillation, Ventricular, Syncope

In brief

The purpose of this study is to test specific device programming in patients without a previous history of a life-threatening, abnormally fast heartbeat who are implanted with a Medtronic ICD (Implantable Cardioconverter Defibrillator) or ICD with CRT (Cardiac Resynchronozation Therapy) device. The information learned from this study could be used to guide physicians in future ICD or CRT device programming.

Key facts

Study ID

NCT00279279

Run by

Medtronic Cardiac Rhythm and Heart Failure

People needed

700

Starts

2003-10-01

Expected to finish

2006-05-01

Last updated by the study team

2006-10-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient is a candidate for a non-replacement Medtronic ICD device from the Marquis family or has had a non-replacement Medtronic Marquis based ICD system implanted within the previous 6 months and has not had any appropriately treated spontaneous VT/VF episodes during that time.

You may not qualify if…

• Patient has history of spontaneous sustained symptomatic ventricular arrhythmias.
• If patient has had an electrophysiology test in the past, and has sustained inducible VT <180 bpm.

Where it is running

• Study site — Birmingham, Alabama, United States
• Study site — Mesa, Arizona, United States
• Study site — Phoenix, Arizona, United States
• Study site — San Diego, California, United States
• Study site — San Pablo, California, United States
• Study site — Newark, Delaware, United States
• Study site — Fort Lauderdale, Florida, United States
• Study site — Jacksonville, Florida, United States
• Study site — Merrit Island, Florida, United States
• Study site — Columbus, Georgia, United States
• Study site — Maywood, Illinois, United States
• Study site — Rockford, Illinois, United States
• Study site — Topeka, Kansas, United States
• Study site — Portland, Maine, United States
• Study site — Silver Spring, Maryland, United States
• Study site — Takoma Park, Maryland, United States
• Study site — Boston, Massachusetts, United States
• Study site — Royal Oak, Michigan, United States
• Study site — Minneapolis, Minnesota, United States
• Study site — Paterson, New Jersey, United States
• Study site — Buffalo, New York, United States
• Study site — New York, New York, United States
• Study site — Columbus, Ohio, United States
• Study site — Elyria, Ohio, United States
• Study site — Bethlehem, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.